RESUMEN
The purinergic signaling has an important role in regulating pancreatic exocrine secretion. The exocrine pancreas is also a site of one of the most serious cancer forms, the pancreatic ductal adenocarcinoma (PDAC). Here, we explore how the network of purinergic and adenosine receptors, as well as ecto-nucleotidases regulate normal pancreatic cells and various cells within the pancreatic tumor microenvironment. In particular, we focus on the P2X7 receptor, P2Y2 and P2Y12 receptors, as well as A2 receptors and ecto-nucleotidases CD39 and CD73. Recent studies indicate that targeting one or more of these candidates could present new therapeutic approaches to treat pancreatic cancer. In pancreatic cancer, as much as possible of normal pancreatic function should be preserved, and therefore physiology of purinergic signaling in pancreas needs to be considered.
Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Antineoplásicos Inmunológicos/uso terapéutico , Carcinoma Ductal Pancreático/tratamiento farmacológico , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Neoplasias Pancreáticas/tratamiento farmacológico , Transducción de Señal/genética , 5'-Nucleotidasa/genética , 5'-Nucleotidasa/inmunología , Animales , Apirasa/genética , Apirasa/inmunología , Carcinoma Ductal Pancreático/genética , Carcinoma Ductal Pancreático/inmunología , Carcinoma Ductal Pancreático/patología , Ensayos Clínicos como Asunto , Proteínas Ligadas a GPI/genética , Proteínas Ligadas a GPI/inmunología , Regulación Neoplásica de la Expresión Génica/inmunología , Humanos , Inmunoterapia/métodos , Páncreas/efectos de los fármacos , Páncreas/inmunología , Páncreas/patología , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/inmunología , Neoplasias Pancreáticas/patología , Células Estrelladas Pancreáticas/efectos de los fármacos , Células Estrelladas Pancreáticas/inmunología , Células Estrelladas Pancreáticas/patología , Receptores de Adenosina A2/genética , Receptores de Adenosina A2/inmunología , Receptores Purinérgicos P2X7/genética , Receptores Purinérgicos P2X7/inmunología , Receptores Purinérgicos P2Y12/genética , Receptores Purinérgicos P2Y12/inmunología , Receptores Purinérgicos P2Y2/genética , Receptores Purinérgicos P2Y2/inmunología , Transducción de Señal/inmunología , Microambiente Tumoral/efectos de los fármacos , Microambiente Tumoral/genética , Microambiente Tumoral/inmunologíaRESUMEN
Chemosensory epithelial cells (EpCs) are specialized cells that promote innate type 2 immunity and protective neurally mediated reflexes in the airway. Their effector programs and modes of activation are not fully understood. Here, we define the transcriptional signature of two choline acetyltransferase-expressing nasal EpC populations. They are found in the respiratory and olfactory mucosa and express key chemosensory cell genes including the transcription factor Pou2f3, the cation channel Trpm5, and the cytokine Il25 Moreover, these cells share a core transcriptional signature with chemosensory cells from intestine, trachea and thymus, and cluster with tracheal brush cells (BrCs) independently from other respiratory EpCs, indicating that they are part of the brush/tuft cell family. Both nasal BrC subsets express high levels of transcripts encoding cysteinyl leukotriene (CysLT) biosynthetic enzymes. In response to ionophore, unfractionated nasal BrCs generate CysLTs at levels exceeding that of the adjacent hematopoietic cells isolated from naïve mucosa. Among activating receptors, BrCs express the purinergic receptor P2Y2. Accordingly, the epithelial stress signal ATP and aeroallergens that elicit ATP release trigger BrC CysLT generation, which is mediated by the P2Y2 receptor. ATP- and aeroallergen-elicited CysLT generation in the nasal lavage is reduced in mice lacking Pou2f3, a requisite transcription factor for BrC development. Last, aeroallergen-induced airway eosinophilia is reduced in BrC-deficient mice. These results identify a previously undescribed BrC sensor and effector pathway leading to generation of lipid mediators in response to luminal signals. Further, they suggest that BrC sensing of local damage may provide an important sentinel immune function.
Asunto(s)
Cisteína/inmunología , Células Epiteliales/inmunología , Leucotrienos/inmunología , Receptores Purinérgicos P2Y2/inmunología , Adenosina Trifosfato , Alérgenos , Animales , Células de la Médula Ósea/inmunología , Células Cultivadas , Femenino , Masculino , Ratones , Mucosa Nasal/inmunología , Tráquea/inmunologíaRESUMEN
In the tumor microenvironment, extracellular nucleotides are released and accumulate, and can activate the P2Y2 receptor (P2Y2R), which regulates various responses in tumor cells, resulting in tumor progression and metastasis. Moreover, the inflammasome has recently been reported to be associated with tumor progression. However, the role of P2Y2R in inflammasome activation in breast cancer cells is not yet well defined. Therefore, in this study, we investigated the role of P2Y2R in inflammasome-mediated tumor progression in breast cancer using breast cancer cells and radiotherapy-resistant (RTR) breast cancer cells. We established RTR-breast cancer cells (RTRMDAMB231, RTRMCF7, and RTR-T47D cells) by repeated irradiation (2 Gy each, 25 times) in a previous study. In this study, we found that the RTR breast cancer cells exhibited an increased release of adenosine triphosphate (ATP) and P2Y2R activity. In particular, the RTRMDAMB231 cells derived from highly metastatic MDAMB231 cells, exhibited a markedly increased ATP release, which was potentiated by tumor necrosis factor (TNF)-α. The MDAMB231 cells exhibited inflammasome activation, as measured by caspase1 activity and interleukin (IL)-1ß secretion following treatment with TNFα and ATP; these effects were enhanced in the RTRMDAMB231 cells. However, the increased caspase1 activities and IL1ß secretion levels induced in response to treatment with TNFα or ATP were significantly reduced by P2Y2R knockdown or the presence of apyrase in both the MDAMB231 and RTRMDAMB231 cells, suggesting the involvement of ATP-activated P2Y2R in inflammasome activation. In addition, TNFα and ATP increased the invasive and colony-forming ability of the MDAMB231 and RTRMDAMB231 cells, and these effects were caspase1-dependent. Moreover, matrix metalloproteinase (MMP)-9 activity was modulated by caspase-1, in a P2Y2R-dependent manner in the MDAMB231 and RTRMDAMB231 cells. Finally, nude mice injected with the RTRMDAMB231-EV cells (transfected with the empty vector) exhibited increased tumor growth, and higher levels of MMP-9 in their tumors and IL1ß levels in their serum compared with the mice injected with the RTRMDAMB231-P2Y2R shRNA cells (transfected with P2Y2R shRNA). On the whole, the findings of this study suggest that extracellular ATP promotes tumor progression in RTR-breast cancer cells and breast cancer cells by modulating invasion and associated molecules through the P2Y2R-inflammasome activation pathway.
Asunto(s)
Adenosina Trifosfato/metabolismo , Neoplasias de la Mama/inmunología , Inflamasomas/inmunología , Tolerancia a Radiación/inmunología , Receptores Purinérgicos P2Y2/metabolismo , Animales , Mama/patología , Neoplasias de la Mama/patología , Neoplasias de la Mama/radioterapia , Línea Celular Tumoral , Progresión de la Enfermedad , Femenino , Humanos , Inflamasomas/metabolismo , Ratones , Ratones Desnudos , Invasividad Neoplásica/inmunología , ARN Interferente Pequeño/metabolismo , Receptores Purinérgicos P2Y2/genética , Receptores Purinérgicos P2Y2/inmunología , Microambiente Tumoral/inmunología , Ensayos Antitumor por Modelo de XenoinjertoRESUMEN
G-protein-coupled P2Y receptors activated by extracellular nucleotides play important roles under different physiological and pathophysiological conditions in mammals. To investigate the immunological relevance of P2Y receptors in fish, we identified and characterized the P2Y2 and P2Y12 receptors in Japanese flounder Paralichthys olivaceus. The P. olivaceus P2Y2 and P2Y12 receptors harbor seven transmembrane domains but share only 24% sequence identity. Real-time PCR analysis revealed the constitutive but unequal mRNA expression pattern of P2Y2R and P2Y12R in normal Japanese flounder tissues with the dominant expression of P2Y2R in head kidney and blood and P2Y12R in hepatopancreas. In addition, the expression of P2Y2 and P2Y12 receptors was markedly modulated by PAMPs stimulation and Edwardsiella tarda infection. Furthermore, blockage of P2Y12R potently increased ADP-activated pro-inflammatory cytokine IL-1beta gene expression in the head kidney macrophages (HKMs). Moreover, inhibition of P2Y2 and P2Y12 receptor activity with their respective potent antagonists significantly altered some of the LPS-induced pro-inflammatory cytokine gene expression in the HKMs. However, blockade of P2Y12R did not affect the poly(I:C)-induced pro-inflammatory cytokine gene expression examined in the HKMs. Collectively, we have for the first time reported the role of purinergic P2Y2 and P2Y12 receptors in fish innate immunity. Our findings have also addressed the importance of extracellular ATP and its metabolites in fish innate immune responses.
Asunto(s)
Enfermedades de los Peces/inmunología , Proteínas de Peces/genética , Proteínas de Peces/inmunología , Peces Planos/genética , Peces Planos/inmunología , Regulación de la Expresión Génica/inmunología , Inmunidad Innata/genética , Secuencia de Aminoácidos , Animales , Edwardsiella tarda/fisiología , Infecciones por Enterobacteriaceae/inmunología , Proteínas de Peces/química , Perfilación de la Expresión Génica/veterinaria , Filogenia , Receptores Purinérgicos P2Y12/química , Receptores Purinérgicos P2Y12/genética , Receptores Purinérgicos P2Y12/inmunología , Receptores Purinérgicos P2Y2/química , Receptores Purinérgicos P2Y2/genética , Receptores Purinérgicos P2Y2/inmunología , Alineación de Secuencia/veterinariaRESUMEN
The epithelial cell-derived cytokines, thymic stromal lymphopoietin (TSLP), interleukin (IL)-25, and IL-33 induce T helper 2 type immune responses. In the present study, we investigate the role of these cytokines in the pathophysiology of eosinophilic chronic rhinosinusitis (ECRS). Nasal tissue specimens from chronic rhinosinusitis patients were assayed for the expression of TSLP, IL-25, IL-33, protease-activated receptor (PAR)-2, and P2Y2 receptor (P2Y2R). Cytokine production in cultured nasal epithelial cells (PNECs) was also examined. The mRNA levels of TSLP and IL-25 and the concentrations of IL-25 and IL-33 increased in PNECs from ECRS patients. Immunohistological staining demonstrated that TSLP, IL-25, and IL-33 were localized in the epithelial cells of nasal polyps, and that their expression was increased in ECRS. The mRNA levels of TSLP and IL-25 correlated with the clinical severity of ECRS, as indicated by the computed tomography score. The TSLP mRNA levels and IL-33 protein concentration correlated with the number of eosinophils in the nasal polyps of patients with ECRS. Airborne allergen-induced cytokine production increased in PNECs of these patients. Expression levels of the PAR-2 and P2Y2R increased in cultured PNECs and nasal polyps from patients with ECRS. The results indicate that increased induction and expression of TSLP, IL-25, and IL-33 from nasal epithelial cells contribute to the pathophysiology of ECRS.
Asunto(s)
Citocinas/genética , Células Epiteliales/inmunología , Interleucina-17/genética , Interleucina-33/genética , Pólipos Nasales/genética , Rinitis/genética , Sinusitis/genética , Adulto , Anciano , Estudios de Casos y Controles , Enfermedad Crónica , Citocinas/inmunología , Eosinófilos/inmunología , Eosinófilos/patología , Células Epiteliales/patología , Femenino , Regulación de la Expresión Génica , Humanos , Interleucina-17/inmunología , Interleucina-33/inmunología , Masculino , Persona de Mediana Edad , Pólipos Nasales/inmunología , Pólipos Nasales/fisiopatología , Pólipos Nasales/cirugía , Cultivo Primario de Células , ARN Mensajero/genética , ARN Mensajero/inmunología , Receptor PAR-2/genética , Receptor PAR-2/inmunología , Receptores Purinérgicos P2Y2/genética , Receptores Purinérgicos P2Y2/inmunología , Rinitis/inmunología , Rinitis/fisiopatología , Rinitis/cirugía , Índice de Severidad de la Enfermedad , Transducción de Señal , Sinusitis/inmunología , Sinusitis/fisiopatología , Sinusitis/cirugía , Linfopoyetina del Estroma TímicoRESUMEN
Urinary tract infections are commonly caused by α-hemolysin (HlyA)-producing Escherichia coli. In erythrocytes, the cytotoxic effect of HlyA is strongly amplified by P2X receptors, which are activated by extracellular ATP released from the cytosol of the erythrocytes. In renal epithelia, HlyA causes reversible [Ca(2+)]i oscillations, which trigger interleukin-6 (IL-6) and IL-8 release. We speculate that this effect is caused by HlyA-induced ATP release from the epithelial cells and successive P2 receptor activation. Here, we demonstrate that HlyA-induced [Ca(2+)]i oscillations in renal epithelia were completely prevented by scavenging extracellular ATP. In accordance, HlyA was unable to inflict any [Ca(2+)]i oscillations in 132-1N1 cells, which lack P2R completely. After transfecting these cells with the hP2Y2 receptor, HlyA readily triggered [Ca(2+)]i oscillations, which were abolished by P2 receptor antagonists. Moreover, HlyA-induced [Ca(2+)]i oscillations were markedly reduced in medullary thick ascending limbs isolated from P2Y2 receptor-deficient mice compared with wild type. Interestingly, the following HlyA-induced IL-6 release was absent in P2Y2 receptor-deficient mice. This suggests that HlyA induces ATP release from renal epithelia, which via P2Y2 receptors is the main mediator of HlyA-induced [Ca(2+)]i oscillations and IL-6 release. This supports the notion that ATP signaling occurs early during bacterial infection and is a key player in the further inflammatory response.
Asunto(s)
Infecciones por Escherichia coli/inmunología , Proteínas de Escherichia coli/inmunología , Escherichia coli/fisiología , Proteínas Hemolisinas/inmunología , Interleucina-6/inmunología , Riñón/microbiología , Receptores Purinérgicos P2Y2/inmunología , Urotelio/microbiología , Adenosina Trifosfato/inmunología , Animales , Señalización del Calcio , Línea Celular , Perros , Escherichia coli/inmunología , Humanos , Riñón/inmunología , Ratones , Urotelio/inmunologíaRESUMEN
UNLABELLED: In addition to their well characterized and established role in haemostasis and thrombosis, platelets contribute to the pathogenesis of inflammation. Adenine nucleotides are signalling molecules that regulate the function of virtually every cell in the body, by interacting with P2 receptors. Their important role in inflammation is well established. In the last few years, the pro-inflammatory roles of adenine nucleotides interacting with their platelet P2 receptors has emerged. In particular, it was shown that the platelet P2Y12 receptor for ADP significantly contributed to the pro-inflammatory effects of cysteinyl leukotrienes (CysLT) in experimental models of asthma in mice. More importantly, it was recently shown that P2Y12 variants were associated with lung function in a large family-based asthma cohort and that the P2Y12 antagonist prasugrel tended to decrease bronchial hyper-reactivity to mannitol in patients with allergic bronchial asthma in a randomized, placebo controlled trial. CONCLUSION: These data strongly suggest that P2Y12 may represent an important pharmacological target for the treatment of patients with allergic bronchial asthma.
Asunto(s)
Asma/inmunología , Plaquetas/inmunología , Inmunidad Innata/inmunología , Modelos Inmunológicos , Activación Plaquetaria/inmunología , Receptores Purinérgicos P2Y2/inmunología , Adenosina Difosfato/inmunología , Animales , HumanosRESUMEN
ATP released in the early inflammatory processes acts as a danger signal by binding to purinergic receptors expressed on immune cells. A major contribution of the P2Y(2) receptor of ATP/UTP to dendritic cell function and Th2 lymphocyte recruitment during asthmatic airway inflammation was previously reported. We investigated here the involvement of P2Y(2) receptor in lung inflammation initiated by pneumonia virus of mice infection. We demonstrated that P2Y(2) (-/-) mice display a severe increase in morbidity and mortality rate in response to the virus. Lower survival of P2Y(2) (-/-) mice was not significantly correlated with excessive inflammation despite the higher level of neutrophil recruiters in their bronchoalveolar fluids. Interestingly, we observed reduced ATP level and lower numbers of dendritic cells, CD4(+) T cells and CD8(+) T cells in P2Y(2) (-/-) compared to P2Y(2) (+/+) infected lungs. Lower level of IL-12 and higher level of IL-6 in bronchoalveolar fluid support an inhibition of Th1 response in P2Y(2) (-/-) infected mice. Quantification of DC recruiter expression revealed comparable IP-10 and MIP-3α levels but a reduced BRAK level in P2Y(2) (-/-) compared to P2Y(2) (+/+) bronchoalveolar fluids. The increased morbidity and mortality of P2Y(2) (-/-) mice could be the consequence of a lower viral clearance leading to a more persistent viral load correlated with the observed higher viral titer. The decreased viral clearance could result from the defective Th1 response to PVM with a lack of DC and T cell infiltration. In conclusion, P2Y(2) receptor, previously described as a target in cystic fibrosis therapy and as a mediator of Th2 response in asthma, may also regulate Th1 response protecting mice against lung viral infection.
Asunto(s)
Pulmón/metabolismo , Virus de la Neumonía Murina/inmunología , Neumonía Viral/metabolismo , Infecciones por Pneumovirus/metabolismo , Receptores Purinérgicos P2Y2/inmunología , Adenosina Trifosfato/metabolismo , Animales , Líquido del Lavado Bronquioalveolar/química , Líquido del Lavado Bronquioalveolar/inmunología , Linfocitos T CD8-positivos/inmunología , Linfocitos T CD8-positivos/virología , Quimiocina CCL20/genética , Quimiocina CCL20/inmunología , Quimiocina CXCL10/genética , Quimiocina CXCL10/inmunología , Quimiocinas CXC/genética , Quimiocinas CXC/inmunología , Células Dendríticas/inmunología , Células Dendríticas/virología , Femenino , Expresión Génica , Inflamación/inmunología , Inflamación/metabolismo , Inflamación/virología , Interleucina-12/genética , Interleucina-12/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Pulmón/inmunología , Pulmón/virología , Ratones , Ratones Noqueados , Neutrófilos/inmunología , Neutrófilos/virología , Neumonía Viral/inmunología , Neumonía Viral/virología , Infecciones por Pneumovirus/inmunología , Infecciones por Pneumovirus/virología , Receptores Purinérgicos P2Y2/deficiencia , Receptores Purinérgicos P2Y2/genética , Tasa de Supervivencia , Células TH1/inmunología , Células TH1/virología , Células Th2/inmunología , Células Th2/virologíaRESUMEN
The therapeutic principle of allogeneic haematopoietic cell transplantation (allo-HCT) is based on an active donor immune system that eliminates host-derived tumour cells. We hypothesized that in addition to the alloantigen-driven anti-tumour response, disruption of the immunological microenvironment within the tumour is responsible for its elimination after allo-HCT. We observed that induction of graft-versus-host disease (GvHD) significantly reduced the abundance of luc(+) FoxP3(+) regulatory T (Treg) cells in the tumour tissue, which is indicative of impaired or over-ridden tumour recruitment signals towards Treg cells. Analysis of the intestines and liver revealed chemokines and purine nucleotides as candidates for attracting Treg to these sites of inflammation. Despite its expression on tissue-residing Treg cells, the chemokine receptor CCR3 was not critical for Treg-cell function following allo-HCT. Extracellular ATP can attract immune cells via P2Y2. P2Y2 was found to be expressed on Treg cells, and we found a partial reduction of GvHD prevention when P2Y2(-/-) rather than P2Y2(+/+) Treg cells were given. Exogenous local inflammation reduced Treg-cell accumulation in the tumour, suggesting a potential clinical approach to prevent Treg-cell-mediated tumour escape. In conclusion, we demonstrate that GvHD-related inflammation reduced Treg-cell numbers at the tumour sites, which may in turn help to explain the observation that patients with GvHD have a lower risk of tumour relapse.
Asunto(s)
Enfermedad Injerto contra Huésped/inmunología , Linfoma de Células B/inmunología , Receptores Purinérgicos P2Y2/inmunología , Linfocitos T Reguladores/inmunología , Animales , Movimiento Celular , Células Cultivadas , Trasplante de Células Madre Hematopoyéticas , Inflamación , Intestinos/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Naftalenos/farmacología , Fenilalanina/análogos & derivados , Fenilalanina/farmacología , Receptores CCR3/antagonistas & inhibidores , Receptores CCR3/metabolismo , Receptores Purinérgicos P2Y2/biosíntesis , Receptores Purinérgicos P2Y2/genética , Transducción de Señal , Linfocitos T Reguladores/metabolismo , Linfocitos T Reguladores/trasplante , Trasplante Homólogo , Microambiente Tumoral/inmunologíaAsunto(s)
Adenosina Trifosfato/inmunología , Quimiotaxis/fisiología , Complemento C5a/inmunología , Macrófagos Peritoneales/inmunología , Fosfatidilinositol 3-Quinasas/inmunología , Agonistas del Receptor Purinérgico P2Y/inmunología , Receptores Purinérgicos P2Y12/inmunología , Receptores Purinérgicos P2Y2/inmunología , Proteínas Quinasas p38 Activadas por Mitógenos/inmunología , Adenosina Difosfato/genética , Adenosina Difosfato/inmunología , Adenosina Difosfato/metabolismo , Adenosina Difosfato/farmacología , Adenosina Trifosfato/metabolismo , Adenosina Trifosfato/farmacología , Animales , Comunicación Autocrina/efectos de los fármacos , Comunicación Autocrina/fisiología , Quimiotaxis/efectos de los fármacos , Complemento C5a/genética , Complemento C5a/metabolismo , Macrófagos Peritoneales/metabolismo , Ratones , Ratones Noqueados , Fosfatidilinositol 3-Quinasas/genética , Fosfatidilinositol 3-Quinasas/metabolismo , Seudópodos/genética , Seudópodos/inmunología , Seudópodos/metabolismo , Agonistas del Receptor Purinérgico P2Y/metabolismo , Agonistas del Receptor Purinérgico P2Y/farmacología , Receptores Purinérgicos P2Y12/genética , Receptores Purinérgicos P2Y12/metabolismo , Receptores Purinérgicos P2Y2/genética , Receptores Purinérgicos P2Y2/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismoRESUMEN
Adenosine 5'-triphosphate (ATP) has been implicated in the recruitment of professional phagocytes (neutrophils and macrophages) to sites of infection and tissue injury in two distinct ways. First, ATP itself is thought to be a chemotactic "find me" signal released by dying cells, and second, autocrine ATP signaling is implicated as an amplifier mechanism for chemotactic navigation to end-target chemoattractants, such as complement C5a. Here we show using real-time chemotaxis assays that mouse peritoneal macrophages do not directionally migrate to stable analogs of ATP (adenosine-5'-(γ-thio)-triphosphate (ATPγS)) or its hydrolysis product ADP (adenosine-5'-(ß-thio)-diphosphate (ADPßS)). HPLC revealed that these synthetic P2Y(2) (ATPγS) and P2Y(12) (ADPßS) receptor ligands were in fact slowly degraded. We also found that ATPγS, but not ADPßS, promoted chemokinesis (increased random migration). Furthermore, we found that photorelease of ATP or ADP induced lamellipodial membrane extensions. At the cell signaling level, C5a, but not ATPγS, activated Akt, whereas both ligands induced p38 MAPK activation. p38 MAPK and Akt activation are strongly implicated in neutrophil chemotaxis. However, we found that inhibitors of phosphatidylinositol 3-kinase (PI3K; upstream of Akt) and p38 MAPK (or conditional deletion of p38α MAPK) did not impair macrophage chemotactic efficiency or migration velocity. Our results suggest that PI3K and p38 MAPK are redundant for macrophage chemotaxis and that purinergic P2Y(2) and P2Y(12) receptor ligands are not chemotactic. We propose that ATP signaling is strictly autocrine or paracrine and that ATP and ADP may act as short-range "touch me" (rather than long-range find me) signals to promote phagocytic clearance via cell spreading.
Asunto(s)
Adenosina Trifosfato/inmunología , Quimiotaxis/fisiología , Complemento C5a/inmunología , Macrófagos Peritoneales/inmunología , Fosfatidilinositol 3-Quinasas/inmunología , Agonistas del Receptor Purinérgico P2Y/inmunología , Receptores Purinérgicos P2Y12/inmunología , Receptores Purinérgicos P2Y2/inmunología , Proteínas Quinasas p38 Activadas por Mitógenos/inmunología , Adenosina Difosfato/genética , Adenosina Difosfato/inmunología , Adenosina Difosfato/metabolismo , Adenosina Difosfato/farmacología , Adenosina Trifosfato/análogos & derivados , Adenosina Trifosfato/metabolismo , Adenosina Trifosfato/farmacología , Animales , Comunicación Autocrina/efectos de los fármacos , Comunicación Autocrina/fisiología , Quimiotaxis/efectos de los fármacos , Complemento C5a/genética , Complemento C5a/metabolismo , Macrófagos Peritoneales/metabolismo , Ratones , Ratones Noqueados , Comunicación Paracrina/efectos de los fármacos , Comunicación Paracrina/fisiología , Fosfatidilinositol 3-Quinasas/genética , Fosfatidilinositol 3-Quinasas/metabolismo , Seudópodos/genética , Seudópodos/inmunología , Seudópodos/metabolismo , Agonistas del Receptor Purinérgico P2Y/metabolismo , Agonistas del Receptor Purinérgico P2Y/farmacología , Receptores Purinérgicos P2Y12/genética , Receptores Purinérgicos P2Y12/metabolismo , Receptores Purinérgicos P2Y2/genética , Receptores Purinérgicos P2Y2/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/genética , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismoRESUMEN
BACKGROUND: Extracellular ATP contributes to the pathogenesis of asthma via signalling at purinergic receptors. However, the precise purinergic receptors subtypes mediating the pro-asthmatic effects of ATP have not been identified, yet. METHODS: In vivo studies were performed using the OVA-alum model. Functional expression of the P2Y(2) purinergic receptor subtype on human monocyte-derived dendritic cells and eosinophils was investigated using real-time PCR, migration assays, and production of reactive oxygen species. RESULTS: Compared to wild-type animals P2Y(2) -/- mice showed reduced allergic airway inflammation which can be explained by defective migration of blood myeloid DCs towards ATP in vitro and in vivo, whereas the influence of ATP on maturation and cytokine production was not changed. Additionally, ATP failed to induce migration of bone marrow-derived eosinophils from P2Y(2) R-deficient animals. The relevance of our findings for humans was confirmed in functional studies with human monocyte-derived DCs and eosinophils. Interestingly, stimulation of human DCs derived from allergic individuals with house dust mite allergen induced functional up-regulation of the P2Y(2) R subtype. Furthermore, eosinophils isolated from asthmatic individuals expressed higher levels of P2Y(2) R compared to healthy controls. This was of functional relevance as these eosinophils were more sensitive to ATP-induced migration and production of reactive oxygen metabolites. CONCLUSIONS: In summary, P2Y(2) R appears to be involved in asthmatic airway inflammation by mediating ATP-triggered migration of mDCs and eosinophils, as well as reactive oxygen species production. Together our data suggest that targeting P2Y(2) R might be a therapeutic option for the treatment of asthma.